企業
企業
75986 件中 9847 位上位 13%今週 2136 位下降
直接の関係 3 件
密接につながる 1534 件のグループに属し、中心は
根拠のある公開の関係から毎日計算しています。
矢印は関係の方向を示します。分野で絞り込めます。
Akeso has out-licensed the exclusive rights to develop and commercialize ivonescimab in the United States and Canada, South America, Europe, the Middle East, Africa, and Japan to Summit Therapeutics under an agreement出典を見る
10 of which are being or have been conducted in China by Akeso出典を見る
the impact of pharmaceutical industry regulation and health care legislation in the P.R. China, the United States and internationally出典を見る
dependence on the effectiveness of Akeso's patents and other protections for innovative products出典を見る
4 件中 1 から 4 件を表示
出典とともに結論を確認し、項目を開いて証拠を読めます。
dependence on the effectiveness of Akeso's patents and other protections for innovative products
PR Newswire news releases · 2026-10-25 23:31
dependence on the effectiveness of Akeso's patents and other protections for innovative products出典を見る
the impact of pharmaceutical industry regulation and health care legislation in the P.R. China, the United States and internationally
PR Newswire news releases · 2026-10-25 23:31
the impact of pharmaceutical industry regulation and health care legislation in the P.R. China, the United States and internationally出典を見る
Eight innovative drugs are commercially available, and two additional drugs with three indications are currently under regulatory review for marketing approval.
PR Newswire news releases · 2026-10-25 23:31
Eight innovative drugs are commercially available, and two additional drugs with three indications are currently under regulatory review for marketing approval.出典を見る
Eight innovative drugs are commercially available, and two additional drugs with three indications are currently under regulatory review for marketing approval.
PR Newswire news releases · 2026-10-25 23:31
Eight innovative drugs are commercially available, and two additional drugs with three indications are currently under regulatory review for marketing approval.出典を見る
Of these, nearly 30 candidates have advanced into clinical trials, including 15 bispecific or multi-specific antibodies and bispecific ADCs.
PR Newswire news releases · 2026-10-25 23:31
Of these, nearly 30 candidates have advanced into clinical trials, including 15 bispecific or multi-specific antibodies and bispecific ADCs.出典を見る
Eight innovative drugs are commercially available, and two additional drugs with three indications are currently under regulatory review for marketing approval.
PR Newswire news releases · 2026-10-25 23:31
Eight innovative drugs are commercially available, and two additional drugs with three indications are currently under regulatory review for marketing approval.出典を見る
16 件中 1 から 6 件を表示
バリュエーションは Pro と Research で利用できます。
Pro で解放この企業について、料金、更新履歴、規約、採用など、見ておくべきページはありますか？ ぜひ提案してください。提案はすべて人が確認します。追加したページはみなさん共通で監視し、続けて2回の取得が一致したときだけ変化として数えます。
利用できません: 企業シグナル · 財務 · 開示資料 · 拠点 · ガイダンス